| scholarly article | Q13442814 |
| P2093 | author name string | Matthew D Scharff | |
| Thomas V McDonald | |||
| Jakub Sroubek | |||
| Yamini Krishnan | |||
| Susan Buhl | |||
| Jordan Chinai | |||
| P2860 | cites work | Differential association between HERG and KCNE1 or KCNE2 | Q21562313 |
| 14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity | Q24294353 | ||
| A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel | Q24316252 | ||
| Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused | Q28142404 | ||
| The genetic basis of long QT and short QT syndromes: a mutation update | Q28262724 | ||
| Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects | Q28374793 | ||
| Long QT Syndrome. | Q33148863 | ||
| The long QT syndrome family of cardiac ion channelopathies: a HuGE review | Q33153638 | ||
| Electrophysiological remodeling in hypertrophy and heart failure | Q33758963 | ||
| Arrhythmias in heart failure: current concepts of mechanisms and therapy | Q33850477 | ||
| Ventricular tachycardia with 2 variable opposing foci | Q34224683 | ||
| Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis | Q35486835 | ||
| Biology of cardiac arrhythmias: ion channel protein trafficking | Q35802024 | ||
| PKA phosphorylation of HERG protein regulates the rate of channel synthesis. | Q37200218 | ||
| Drug-induced hERG block and long QT syndrome | Q37734559 | ||
| Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein | Q38328649 | ||
| Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells | Q39971749 | ||
| Production of monoclonal antibodies: strategy and tactics | Q40300743 | ||
| Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism | Q40326013 | ||
| Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. | Q40643919 | ||
| Metabolic inhibition of ICa,L and IK differs in feline left ventricular hypertrophy. | Q51639096 | ||
| Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. | Q53256610 | ||
| International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice. | Q53265213 | ||
| Somatic cell genetic analysis of myelomas and hybridomas | Q68543636 | ||
| VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome | Q80125721 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 215-222 | |
| P577 | publication date | 2011-11-15 | |
| P1433 | published in | Journal of Immunological Methods | Q15755939 |
| P1476 | title | The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel | |
| P478 | volume | 375 |
| Q34539842 | A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses | cites work | P2860 |
Search more.